The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global automatic pill dispenser machine market reached a value of US$ 2.79 Billion in 2021. Looking forward, IMARC Group expects the market to reach a value of US$ 4.51 Billion by 2027, exhibiting a CAGR of 8.10% during 2022-2027. Keeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic on different end use sectors. These insights are included in the report as a major market contributor.
Automatic pill dispenser (APD) machines refer to medical devices that are designed to dispense the right medication at required amounts. Robotic, pharmacy-based, carousels, ward-based and automated unit dose are some of the common dispensing systems. These machines consist of an LED display, an alarm system, motor controller, pill container, and microcontroller interface with an alphanumeric keypad and dispenser. APD machines are widely used to simplify medication management and help individual to take their prescribed medications and supplements at specified date and time. They assist in scheduling medications, reducing human errors and decreasing the risk of accidental overdosing and underdosing. As a result, APD machines are widely used in home pharmacies, visual impairment centers, hospital pharmacies, old age homes and physical disability centers.
The rising geriatric population that are more prone to developing chronic diseases, such as cardiovascular diseases, cancer, diabetes, and chronic obstructive pulmonary disease are driving the automatic pill dispensing machine market growth. In line with this, the widespread product adoption by patients suffering from memory loss to provide accurate dosage and reduce the incidences of overdose and dosage skip are augmenting the market growth. Moreover, the introduction of smart pill dispensers integrated with artificial intelligence (AI) that aids in facial and voice recognition to provide the correct pills to the patients are providing an impetus to the market growth. Additionally, the increasing product demand to reduce medical errors that lead to lethal side effects, such as unwanted lifetime disability, gastrointestinal issues and skin reactions is positively impacting the market growth. Other factors, including the implementation of various government initiatives to improve healthcare facilities and the increasing need for self-care and home-based treatments due to hectic lifestyles and busy schedules, are anticipated to drive the market further toward growth.
IMARC Group provides an analysis of the key trends in each sub-segment of the global automatic pill dispenser machine market, along with forecasts at the global, regional and country level from 2022-2027. Our report has categorized the market based on type and application.
Breakup by Type:
Breakup by Application:
Breakup by Region:
The competitive landscape of the industry has also been examined along with the profiles of the key players being Becton Dickinson and Company, Capsa Healthcare, Cerner Corporation, Lifeline Systems Inc. (Royal Philips Electronics), McKesson Corporation, Omnicell Inc., ScriptPro LLC, Talyst LLC (Swisslog Healthcare) and Yuyama Co. Ltd.
|Base Year of the Analysis||2021|
|Segment Coverage||Type, Application, Region|
|Region Covered||Asia Pacific, Europe, North America, Latin America, Middle East and Africa|
|Countries Covered||United States, Canada, Germany, France, United Kingdom, Italy, Spain, Russia, China, Japan, India, South Korea, Australia, Indonesia, Brazil, Mexico|
|Companies Covered||Becton Dickinson and Company, Capsa Healthcare, Cerner Corporation, Lifeline Systems Inc. (Royal Philips Electronics), McKesson Corporation, Omnicell Inc., ScriptPro LLC, Talyst LLC (Swisslog Healthcare) and Yuyama Co. Ltd.|
|Customization Scope||10% Free Customization|
|Report Price and Purchase Option||Single User License: US$ 2499
Five User License: US$ 3499
Corporate License: US$ 4499
|Post-Sale Analyst Support||10-12 Weeks|
|Delivery Format||PDF and Excel through Email (We can also provide the editable version of the report in PPT/Word format on special request)|
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at